179 related articles for article (PubMed ID: 36011408)
1. Genetic Variants Associated with Elevated Plasma Ceramides in Individuals with Metabolic Syndrome.
Lee S; Kim SA; Kim Y; Kim J; Hong G; Hong J; Choi K; Eom CS; Baik S; Lee MK; Lee KR
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011408
[TBL] [Abstract][Full Text] [Related]
2. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
Ge K; Zheng D; Wang J; Jia W; Zhao A
Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
[TBL] [Abstract][Full Text] [Related]
3. Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.
Warshauer JT; Lopez X; Gordillo R; Hicks J; Holland WL; Anuwe E; Blankfard MB; Scherer PE; Lingvay I
Diabetes Metab Res Rev; 2015 Oct; 31(7):734-44. PubMed ID: 25959529
[TBL] [Abstract][Full Text] [Related]
4. Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.
Chung JO; Koutsari C; Blachnio-Zabielska AU; Hames KC; Jensen MD
Diabetes; 2017 Aug; 66(8):2082-2091. PubMed ID: 28483801
[TBL] [Abstract][Full Text] [Related]
5. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.
Haus JM; Kashyap SR; Kasumov T; Zhang R; Kelly KR; Defronzo RA; Kirwan JP
Diabetes; 2009 Feb; 58(2):337-43. PubMed ID: 19008343
[TBL] [Abstract][Full Text] [Related]
6. Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species.
Mielke MM; Bandaru VV; Han D; An Y; Resnick SM; Ferrucci L; Haughey NJ
Aging Cell; 2015 Dec; 14(6):1014-23. PubMed ID: 26193443
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
8. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.
Lopez X; Goldfine AB; Holland WL; Gordillo R; Scherer PE
J Pediatr Endocrinol Metab; 2013; 26(9-10):995-8. PubMed ID: 23612696
[TBL] [Abstract][Full Text] [Related]
9. Ceramide metabolism in mouse tissue.
Schiffmann S; Birod K; Männich J; Eberle M; Wegner MS; Wanger R; Hartmann D; Ferreiros N; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1886-94. PubMed ID: 23792024
[TBL] [Abstract][Full Text] [Related]
10. Plasma C18:0-ceramide is a novel potential biomarker for disease severity in myasthenia gravis.
Zhang Z; Huang X; Du X; Wang Z; Wang Y; Xu M; Chen X; Yao Q; Yan L; Zhang Y
J Neurochem; 2023 Jun; 165(6):907-919. PubMed ID: 37158660
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.
Denimal D; Bergas V; Pais-de-Barros JP; Simoneau I; Demizieux L; Passilly-Degrace P; Bouillet B; Petit JM; Rouland A; Bataille A; Duvillard L; Vergès B
Cardiovasc Diabetol; 2023 May; 22(1):104. PubMed ID: 37143040
[TBL] [Abstract][Full Text] [Related]
12. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
[TBL] [Abstract][Full Text] [Related]
13. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A
Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720
[TBL] [Abstract][Full Text] [Related]
15. Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study.
Buie JNJ; Hammad SM; Nietert PJ; Magwood G; Adams RJ; Bonilha L; Sims-Robinson C
PLoS One; 2019; 14(5):e0216213. PubMed ID: 31067249
[TBL] [Abstract][Full Text] [Related]
16. Associations between plasma ceramides and mortality in patients with coronary artery disease.
Li Q; Wang X; Pang J; Zhang Y; Zhang H; Xu Z; Chen Q; Ling W
Atherosclerosis; 2020 Dec; 314():77-83. PubMed ID: 32980131
[TBL] [Abstract][Full Text] [Related]
17. Nano-LC-MS/MS for the quantitation of ceramides in mice cerebrospinal fluid using minimal sample volume.
Thomas D; Eberle M; Schiffmann S; Zhang DD; Geisslinger G; Ferreirós N
Talanta; 2013 Nov; 116():912-8. PubMed ID: 24148494
[TBL] [Abstract][Full Text] [Related]
18. Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients.
La Corte E; Dei Cas M; Raggi A; Patanè M; Broggi M; Schiavolin S; Calatozzolo C; Pollo B; Pipolo C; Bruzzone MG; Campisi G; Paroni R; Ghidoni R; Ferroli P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514293
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma.
Jiang H; Hsu FF; Farmer MS; Peterson LR; Schaffer JE; Ory DS; Jiang X
Anal Bioanal Chem; 2013 Sep; 405(23):7357-65. PubMed ID: 23857140
[TBL] [Abstract][Full Text] [Related]
20. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
